Navigation Links
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Date:11/30/2009

WAYNE, N.J. and CHICAGO, Nov. 30 /PRNewswire/ -- Today at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Bayer HealthCare Pharmaceuticals Inc. announced the enrollment of the first patient in an international Phase III clinical trial to evaluate the efficacy and safety of florbetaben (BAY 94-9172) PET imaging in the detection of beta-Amyloid plaques in the brain, which are a pathological hallmark of Alzheimer's disease.

At present, diagnosis of Alzheimer's disease is based on cognitive tests that can only indicate a probability of having the disease. A definitive diagnosis of Alzheimer's disease is only possible through a post-mortem autopsy or brain tissue biopsy.

"We are pleased that with the initiation of the florbetaben Phase III clinical trials Bayer is moving forward on the development of a diagnostic tool that has the potential to enable a more definitive and earlier diagnosis of Alzheimer's disease," said Douglas Stefanelli, Vice President and General Manager, Diagnostic Imaging, Bayer HealthCare Pharmaceuticals.

Phase III Trial Design

The pivotal phase III trial is an open-label, multi-center, non-randomized single dose
study to assess the safety and to determine the sensitivity and specificity of the visual and quantitative assessment of regional tracer uptake of florbetaben in the brain using PET imaging. Approximately 400 individuals are expected to be enrolled in this study. The florbetaben uptake pattern will be visually assessed by independent nuclear medicine physicians blinded to the clinical diagnosis and all other clinical data. The images will be compared for the presence or absence of cerebral beta-Amyloid plaques respective to corresponding histo-pathological specimens. Both volunteers without dementia and patients with dementia will be included.

The primary and secondary objectives of the trial are the
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is ... ® Complete Knee System. , ... year since Zimmer first introduced the NexGen knee system, ... more than five million implantations of the NexGen knee have ... NexGen knee demonstrates the importance of design innovation and component ...
(Date:3/27/2015)... March 27, 2015 XRpro Sciences, Inc., ... discovery and development services which features high throughput ... industry, announced financial results for the year ended ...  Tyson, Chairman of XRpro Sciences commented, "We have ... from development stage to commercial stage in large ...
(Date:3/27/2015)... , March 27, 2015 Report ... for leading ophthalmic drug companies  What does ... pharma ophthalmic industry ? Visiongain,s brand new report shows ... and prospects there. Our 242-page report provides ... areas in the industry and the future market prospects. ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... FRANKLIN LAKES, N.J., Jan. 24, 2011 Medco Health ... announce its fourth-quarter and full-year 2010 financial results in ... February 22, 2011.   (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO) ... call to review the financial results, outlook and related ...
... ICAP Ocean Tomo ... (IAP.L) and the world,s premier patent auction firm, announces ... Till Keesmann. Consisting of seven issued patents and seven ... of interest to companies involved in areas such as ...
Cached Medicine Technology:Medco Announces Date for Release of Fourth-Quarter and Full-Year 2010 Financial Results 2Cutting Edge Nanotech Patents for Displays, Lighting, X-ray, Medical Imaging, and Diagnostics Available for Sale by ICAP Ocean Tomo 2
(Date:3/28/2015)... (PRWEB) March 28, 2015 Healthpointe’s otolaryngologists, ... nose and throat disorders, are now offering a ... common issue which is characterized by the presence of ... in 5 people, tinnitus is a prevalent symptom that ... while it is non-fatal, tinnitus can impede a person’s ...
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s Wellness Celebration ... Conference Center in Chesapeake, Virginia. Each year, ARDX celebrates ... in the Hampton Roads region. The 2015 Women’s History ... Women grow stronger through sharing their stories and learning the ... WWC™ theme is T-talk where we will share a cup ...
(Date:3/28/2015)... LTW Cyber is an innovation hub ... the purpose of addressing the needs of the global ... own opportunities to grow while seeking collaborative opportunities with ... , Ventures in LTW Cyber focus on secure application ... identifying vulnerabilities and analyzing open source. As the ...
(Date:3/27/2015)... In her mid-forties and with a lifelong ... Monica K. arrived at JET Uniform & Supply ... and scared. The owners and staff at JET, which had ... to offer jobs to challenged residents like Monica, were patient. ... to begin with the end in mind,” says Stephen Milaney, ...
(Date:3/27/2015)... First Choice Emergency Room opened its ... located 12665 W Lake Houston Pkwy, Houston, Texas and is ... look forward to delivering the highest quality emergency medical care ... of First Choice Emergency Room Summerwood. , To ... to Summer Creek High School at First Choice Emergency Room’s ...
Breaking Medicine News(10 mins):Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2
... will Offer Attendees the Latest Resources and Education to ... With consumers paying closer attention to price and 45% ... contract manufacturer resources, the new Private Label/Contract Manufacturing Pavilion ... activity. Taking place September 15-17, 2009 at the ...
... Clean & Safe Ports Calls on Members of Congress ... Improve Safety & SecurityLOS ANGELES and WASHINGTON, April 16 ... the air and create good green jobs at our ... for Clean & Safe Ports in California celebrated U.S. ...
... to other pathogens , , THURSDAY, April 16 (HealthDay News) ... invade cells that line the intestine and hijack cellular ... Their finding offers new insight into how disease is ... people a year. , "In evolutionary terms, this hijacking ...
... to Dieter,s LifestyleOWINGS MILLS, Md., April 16 Medifast, Inc. ... of its newest Medifast Weight Control Center in Austin, Tx. ... Shops at Arbor Trails, 4301 W. William Cannon, Bldg. B. ... Center are M-F 10 a.m.-7 p.m. and Saturday 9 a.m.-3 ...
... A Queen,s University research team has found that ... as frequently in adolescent boys. Chronic prostatitis or chronic ... with persistent and life-altering pelvic and genital pain. ... prevalence of CP-like symptoms in adolescent males, and to ...
... Elsevier and the,American College of ... ( http://www.elsevier.com/locate/jacima ) (ISSN: 1936-878X) and ... have been selected for coverage in ... of Medicine(R), MEDLINE (Medical Literature Analysis ...
Cached Medicine News:Health News:HBA Global Expo Platforms Private Label/Contract Manufacturing 2Health News:HBA Global Expo Platforms Private Label/Contract Manufacturing 3Health News:Public Health is No. 1, Says U.S. District Judge in Denial of FMC Motion to Shelve the LA-LB Clean Trucks Programs 2Health News:Public Health is No. 1, Says U.S. District Judge in Denial of FMC Motion to Shelve the LA-LB Clean Trucks Programs 3Health News:Public Health is No. 1, Says U.S. District Judge in Denial of FMC Motion to Shelve the LA-LB Clean Trucks Programs 4Health News:Public Health is No. 1, Says U.S. District Judge in Denial of FMC Motion to Shelve the LA-LB Clean Trucks Programs 5Health News:Medifast Weight Control Center Opens in Austin, TX 2Health News:Pelvic pain as prevalent in teens as older males, Queen's researchers discover 2Health News:JACC: Cardiovascular Imaging and JACC: Cardiovascular Interventions Accepted for Coverage In MEDLINE(R) 2Health News:JACC: Cardiovascular Imaging and JACC: Cardiovascular Interventions Accepted for Coverage In MEDLINE(R) 3
... Adapter in conjunction with the Vortex Genie 2 ... Mo Bio Vortex Adapter is an inexpensive alternative ... which offer the same technology. This particular ... one time and will fit any Vortex Genie ...
Use the Mo Bio Vortex Adapter in conjunction with the Vortex Genie 2 for rapid bead beating procedures. Using the Mo Bio Vortex Adapter is an inexpensive alternative to other bead beating and Fast Pr...
... with Vacuum Controller V-800 and water-cooled secondary condenser ... Compact Housing Model V-500 is ... handle most vacuum applications. Applications ... rotary evaporators Laboratory vacuum source for ...
... BchiVac V-500 with Vacuum Controller V-800 and water-cooled ... from Model V-500 is a ... most vacuum applications. Applications Ideally ... evaporators Laboratory vacuum source for instruments ...
Medicine Products: